Increase in bone turnover markers in HIV patients treated with tenofovir disoproxil fumarate combined with raltegravir or efavirenz()

INTRODUCTION: Accelerated bone loss and osteoporosis are multifactorial comorbidities related to HIV and its treatments; however, their mechanisms remain elusive. Identifying HIV treatments that are differentially linked to osteoporosis risk, and clinical factors associated with HIV-related osteopor...

Descripción completa

Detalles Bibliográficos
Autores principales: Oster, Yonatan, Cohen, Matan J., Dresner-Pollak, Rivka, Szalat, Auryan, Elinav, Hila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607241/
https://www.ncbi.nlm.nih.gov/pubmed/33163587
http://dx.doi.org/10.1016/j.bonr.2020.100727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607241/
https://www.ncbi.nlm.nih.gov/pubmed/33163587
http://dx.doi.org/10.1016/j.bonr.2020.100727

Ejemplares similares